#Ozempic is making headlines, but here’s what most people don’t know:
🔬 Light-sheet fluorescence microscopy is key to uncovering how the drug enters the brain and where it travels once it’s there.

A powerful technique helping us see beyond the hype, right into the science.

1/2

“.. one big challenge is actually the variation in the data ..”
Yes, Johanna Perens (from Gubra), as a fellow image analyst, I couldn’t agree more.

Especially during data exploration, it can be challenging to know what is “signal”, “noise”, or “variation”.
1/2

🚧 Designing trials in rare diseases is hard.
Few patients. Scattered expertise. Complex endpoints.

In this Keep It Science #podcast episode, we explore with Dr Karen Skinner (LifeArc) and
Dr Greg Gordon (@SRFcure) what makes rare disease research possible.
1/2

🚨 New episode drop: Rare Disease Research Landscape
What does it take to make real progress in rare disease science?

In this Keep It Science episode, we talk with Dr Karen Skinner, COO LifeArc and Dr Gregory Gordon, CMO @srfcure Scleroderma Research Foundation.

Listen now: youtu.be/L2GvDNGV9BE

🎙️ Bruker Conversations on AFM with Dr. Craig Prater

We explored how AFM-IR combines Atomic Force Microscopy with infrared spectroscopy to perform chemical analysis on a nanoscale level.

Listen here: www.youtube.com/watch?v=1MsX...

#podcast #science #sciencepodcast #afm